Exact Mass: 360.032
Exact Mass Matches: 360.032
Found 196 metabolites which its exact mass value is equals to given mass value 360.032,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pyraclofos
D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
dorzolamide hydrochloride
D004791 - Enzyme Inhibitors > D002257 - Carbonic Anhydrase Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C471 - Enzyme Inhibitor > C29577 - Carbonic Anhydrase Inhibitor
2-(3-Benzyltriazolo[4,5-d]pyrimidin-7-yl)sulfanyl-1,3-benzoxazole
VAS2870 is a NADPH oxidase (NOX) inhibitor.
4-Methylgallic acid 3-glucuronide
4-Hydroxy-3-(2'-hydroxy-[1,1'-biphenyl]-4-yl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile
fructose-6-phosphate pyruvate
Ritipenem acetoxymethyl ester
Glucoputranjivin
Glucoputranjivin is a member of the class of compounds known as alkylglucosinolates. Alkylglucosinolates are organic compounds containing a glucosinolate moiety that carries an alkyl chain. Glucoputranjivin is soluble (in water) and an extremely strong acidic compound (based on its pKa). Glucoputranjivin can be found in a number of food items such as wasabi, white mustard, chinese mustard, and horseradish, which makes glucoputranjivin a potential biomarker for the consumption of these food products.
ethyl loflazepate
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
{3-[5-(2-Phenyleth-1-ynyl)-2-thienyl]-1H-pyrazol-1-yl}(2-thienyl)methanone
1,3,6,8-Tetrahydroxy-7-hydroxymethyl-9,10-dioxo-9,10-dihydro-anthracen-2-carbonsaeure-methylester|1,3,6,8-tetrahydroxy-7-hydroxymethyl-9,10-dioxo-9,10-dihydro-anthracene-2-carboxylic acid methyl ester|2-Hydroxymethyl-1,3,6,8-tetrahydroxyanthrachinon-7-carbonsaeure-methylester|Rhodocadonsaeure
Methyl 18-Bromo-(13E,17E)-octadeca-9,17-diene-5,7,15-triynoate
6-bromo-(5E,15Z)-octadeca-5,15-diene-11,13,17-triynoic acid methyl ester
(3Z,11Z,7S*,9R*,10R*)-13-methoxy-6-chloro-9-bromo-7:10-epoxypentadeca-3,11-dien-1-yne
3,3,4-tri-O-methylflavellagic acid|3,3,4-trimethoxyflavellagic acid
1-[(Z)-but-2-en-2-yl]-8-chloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one
1-[(Z)-but-2-en-2-yl]-8-chloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one [IIN-based on: CCMSLIB00000848321]
1-[(Z)-but-2-en-2-yl]-8-chloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one [IIN-based: Match]
Methyl 18-bromo-9E,17E-octadecadien-5,7,15-triynoate
Methyl 18-bromo-9Z,17E-octadecadien-5,7,15-triynoate
Methyl 18-bromo-13E,17E-octadecatrien-5,7,15-triynoate
Methyl 18-bromo-9E,17E-octadecadien-5,7,15-triynoate
Methyl 18-bromo-9Z,17E-octadecadien-5,7,15-triynoate
Methyl 18-bromo-13E,17E-octadecatrien-5,7,15-triynoate
Ixazomib
A glycine derivative that is the amide obtained by formal condensation of the carboxy group of N-(2,5-dichlorobenzoyl)glycine with the amino group of [(1R)-1-amino-3-methylbutyl]boronic acid. The active metabolite of ixazomib citrate, it is used in combination therapy for treatment of multiple myeloma. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XG - Proteasome inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2160 - Proteasome Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors D000970 - Antineoplastic Agents C471 - Enzyme Inhibitor
6-AMINO-2-(BENZO[D][1,3]DIOXOL-5-YLMETHYL)-4-BROMOISOINDOLIN-1-ONE
Fosazepam
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
Urea, N-(3,4-dichlorophenyl)-N-(5,7-dimethyl-1,8-naphthyridin-2-yl)- (9CI)
ETHYL 3-(4-BROMOPHENYL)-4-CYANO-5-ETHYL-1-METHYL-1H-PYRROLE-2-CARBOXYLATE
2-(2-Iodo-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
A-769662
A-769662 is a potent, reversible AMPK activator with EC50 of 0.8 μM.
methyl 4-(4-chloro-[1]benzothiolo[2,3-d]pyrimidin-2-yl)cyclohexane-1-carboxylate
2-[2-[4-(4-chlorophenoxy)anilino]-1,3-thiazol-4-yl]acetic acid
Hexamethonium bromide
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D005730 - Ganglionic Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents > D006584 - Hexamethonium Compounds D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists Hexamethonium Bromide is a non-selective ganglionic nicotinic-receptor antagonist (nAChR) antagonist, with mixed competitive and noncompetitive activity. Hexamethonium Bromide has anti-hypertensive activity. Hexamethonium Bromide attenuates sympathetic activity and blood pressure in spontaneously hypertensive animal models[1][2][3][4].
2-(5-bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene
1-(3,4-DIFLUOROBENZYL)-2-OXO-N-(THIOPHEN-2-YLMETHYL)-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE
a-D-erythro-Pentofuranosyl chloride, 2-deoxy-, dibenzoate (9CI)
4-Chloro-1-(phenylsulfonyl)-5-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine
2-Iodo-4-methyl-3-(3-pyridinyl)-1H-pyrrolo[2,3-b]pyridine-5-carbo nitrile
Methyl 4-O-benzoyl-6-bromo-6-deoxy-α-D-glucopyranoside
Ethyl2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-fluorobenzoate
1-[3,6-bis(4-chlorophenyl)-1H-1,2,4,5-tetrazin-2-yl]propan-1-one
TGR5 Receptor Agonist
TGR5 Receptor Agonist (CCDC), a potent Takeda G protein-coupled receptor 5 (TGR5; GPCR19) agonist, shows improved potency in the U2-OS cells and melanophore cells with pEC50s of 6.8 and 7.5, respectively. TGR5 Receptor Agonist can induce peripheral and central hypersensitivity to bladder distension in mice, and increase intracellular Ca2+ concentration. TGR5 Receptor Agonist can also reduces food intake and improves insulin responsiveness, in diet-induced obese mice. TGR5 Receptor Agonist can be used to research diabetes, bladder hypersensitivity and anti-obesity[1][2][3][4].
3-iodo-4-[(4-methylpiperazin-1-yl)methyl]benzoic acid
2-(1,3-Benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole
2-[2-(1,2-benzisoxazol-3-yl)acetyl]-N-(4-chlorophenyl)-1-hydrazinecarbothioamide
2-[4-Ethoxy-2-[2-furanyl(oxo)methyl]imino-1,3-benzothiazol-3-yl]acetic acid methyl ester
2,5-dichloro-4-ethoxy-N-(2-pyridinylmethyl)benzenesulfonamide
N-[(2-methyl-4-thiazolyl)methyl]-4-phenoxybenzenesulfonamide
4,5-Dichloro-2-[oxo-(8-quinolinylamino)methyl]benzoic acid
1-(4-Chlorophenyl)-2-[[3-(3-methylphenyl)-1,2,4-thiadiazol-5-yl]thio]ethanone
2-bromo-N-[2,3-dihydroindol-1-yl(sulfanylidene)methyl]benzamide
(2E,5E)-2-((2-chlorophenyl)imino)-5-(4-hydroxy-3-methoxybenzylidene)thiazolidin-4-one
O-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)ethyl] (4-Chlorophenyl)thiocarbamate
4-Phosphonooxy-phenyl-methyl-[4-phosphonooxy]benzen
N1-(5-Phospho-alpha-ribosyl)-5-methoxybenzimidazole
CID 22635267
D010575 - Pesticides > D006540 - Herbicides D004791 - Enzyme Inhibitors D016573 - Agrochemicals
[5,6,7,8-Tetrahydroxy-8-(hydroxymethyl)-2-oxo-1,3,9-trioxa-2lambda5-phosphaspiro[3.5]nonan-2-yl] 2-oxopropaneperoxoate
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-oxo-3,4-dihydro-1H-quinoline-6-sulfonamide
(E)-2-cyano-N-(2,4-dichlorophenyl)-3-[5-(2-methylcyclopropyl)furan-2-yl]prop-2-enamide
N-[(E)-(6-chloro-1,3-benzodioxol-5-yl)methylideneamino]-2,3-dihydro-1,4-benzodioxine-6-carboxamide
(1S,3S,11R,11aR)-3-amino-1,7,11-trihydroxy-4-oxo-1,3,4,6,11,11a-hexahydro-2H-pyrido[1,2-b]isoquinolin-8-yl hydrogen sulfate
3-(4-Bromophenyl)-5-(3,5-dimethoxyphenyl)-1,2,4-oxadiazole
2-(ethylthio)-4-{[5-(2-nitrophenyl)-2-furyl]methylene}-1,3-thiazol-5(4H)-one
N-(5-chloro-2-pyridinyl)-2-[(1-phenyl-5-tetrazolyl)thio]propanamide
N-(1,3-benzodioxol-5-yl)-6-bromo-2-pyrazolo[1,5-a]pyrimidinecarboxamide
1-(4-Fluorophenyl)-3-methyl-5-thieno[2,3-c]pyrazolecarboxylic acid (2-oxo-3-oxolanyl) ester
5-[(2-Bromophenyl)methyl]-1-tert-butyl-4-pyrazolo[3,4-d]pyrimidinone
2-(4-Chlorophenyl)-3-(2-furanylmethyl)imidazo[4,5-b]quinoxaline
N-[[[(2-hydroxyphenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]-2-nitrobenzamide
5-(4-Chlorophenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine
2-Amino-4-(4-chlorophenyl)-1-(4-methylphenyl)-6-oxopyridine-3,5-dicarbonitrile
2-Amino-1-(4-chlorophenyl)-4-(4-methylphenyl)-6-oxopyridine-3,5-dicarbonitrile
2-[[5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-yl]thio]acetic acid butyl ester
N-(4-chlorophenyl)-3-[(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)thio]propanamide
fumisoquin B zwitterion
A zwitterion obtained by transfer of a proton from the sulfate to the amino group of fumisoquin B; major species at pH 7.3.
5-(2-Chlorophenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine
N-[(E)-[5-(2-chlorophenyl)furan-2-yl]methylideneamino]benzenesulfonamide
(2R)-2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoate
(4S,trans)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride
N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-aminium
1-S-[(1Z)-N-(sulfonatooxy)butanimidoyl]-1-thio-beta-D-glucopyranose
(2S)-2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoate
6-(5-Carboxy-2-hydroxy-3-methoxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
2-cyano-N-(2,4-dichlorophenyl)-3-[5-(2-methylcyclopropyl)-2-furanyl]-2-propenamide
propylglucosinolate
An alkylglucosinolate that is the conjugate base of propylglucosinolic acid.
fumisoquin B
A pyridoisoquinoline that is (11aR)-1,3,4,6,11,11a-hexahydro-2H-pyrido[1,2-b]isoquinoline substituted by hydoxy groups at positions 1S,7 and 11R, by an amino group at position 3S, oxo group at position 4 and a sulfooxy group at position 8. It is produced by a biosynthetic gene cluster called fsq in the human pathogen Aspergillus fumigatus.
Glucoputranjivin(1-)
A alkylglucosinolate that is the conjugate base of glucoputranjivin.
7-Iodo-2',3'-dideoxy-7-deazaadenosine
7-Iodo-2',3'-dideoxy-7-deazaadenosine is a dideoxynucleoside that can be used in DNA synthesis and sequencing reactions[1].
FX-909
FX-909 is a covalent peroxisome proliferator-activated receptor gamma (PPARG) inverse agonist. FX-909 can be used for the research of cancer[1].
RO0711401
RO0711401 is a selective and orally active positive allosteric modulator of mGlu1 receptor with an EC50 of 56 nM[1][2].
SSR180711 (hydrochloride)
SSR180711 hydrochloride is an orally active, selective and reversible α7 acetylcholine nicotinic receptor (n-AChRs) partial agonist. SSR180711 hydrochloride can act on rat α7 n-AChR (Ki=22 nM; IC50=30 nM) and human α7 n-AChR (Ki=14 nM; IC50=18 nM). SSR180711 hydrochloride increases glutamatergic neurotransmission, ACh release and long-term potentiation (LTP) in the hippocampus[1].
(2-{[2,3'-bithiophen]-2'-yl}-2h-thiophen-3-ylidene)methyl (2z)-2-methylbut-2-enoate
(2r,3r,5s)-3-bromo-5-(1-chlorohex-3-en-5-yn-1-yl)-2-(3-methoxypent-1-en-1-yl)oxolane
5-chloro-6-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-8-hydroxy-3-methyl-3,4-dihydro-2-benzopyran-1-one
6,12-dihydroxy-7,13,14-trimethoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione
4-[(2z)-but-2-en-2-yl]-13-chloro-6,14-dihydroxy-7,12-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
3,5,3′- tri- Omethylflavellagic acid
{"Ingredient_id": "HBIN007535","Ingredient_name": "3,5,3\u2032- tri- Omethylflavellagic acid","Alias": "NA","Ingredient_formula": "C17H12O9","Ingredient_Smile": "COC1=C(C=C2C3=C1OC(=O)C4=C3C(=C(C(=C4O)OC)OC)OC2=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41520","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
